当前位置:

网站首页>文章详情

FFR阳性值小于0.71冠心病患者介入治疗的预后

【PDF在线阅读】 【下载PDF】

摘要:

目的 评估冠状动脉粥样硬化性心脏病(冠心病)介入治疗中血流储备分数(FFR)小于 0.71患者的预后。方法 纳入于北京大学首钢医院行介入治疗且FFR测定≤0.8的60例冠心病患者。根据 FFR值分为两组:试验组(FFR值≤0.71),24例;对照组(0.71<FFR值≤0.8),36例。两组患者均给 予经皮冠状动脉介入治疗(PCI),随访1年,比较两组之间主要不良心血管事件(MACE)的发生率。 结果 两组患者基础资料无差异,在冠状动脉介入治疗情况以及术后用药情况方面无差异(P>0.05), 术后1年内再次血运重建、急性心肌梗死、死亡、再发心绞痛等方面无明显差异(P>0.05),而试验组 患者(37.5%)在总的主要不良心血管事件(MACE)发生率高于对照组(8.3%),差异具有显著统计学 意义(P<0.01)。结论 冠心病患者介入治疗中FFR≤0.71的患者预后更差。

Abstract:

Objective To evaluate the prognosis of patients with coronary heart disease and Fractional Flow reserve (FFR) value less than 0.71 in Percutaneous Coronary Intervention (PCI). Methods 60 patients with coronary atherosclerotic heart disease (coronary heart disease) who received interventional treatment at Peking University Shougang Hospital and whose FFR was ≤ 0.8 were divided into two groups according to the FFR value, including the experimental group (FFR value ≤ 0.71, 24 cases) and control group (0.71 0.05). There was no significant difference in revascularization, acute myocardial infarction, death, and recurrent angina within 1 year after operation (P>0.05). The total incidence of major adverse cardiovascular events (MACE) in patients in the test group (37.5%) was higher than that in the control group (8.3%), and the difference was statistically significant (P<0.01). Conclusions Patients with coronary heart disease have a worse prognosis in patients with FFR ≤ 0.71 during interventional therapy.

基金项目:

参考文献:

  • 2008

  • 1

通讯地址:北京市东城区东四十条南门仓5号
电话: 237499284 邮编:100700
网址:www.ebcvm..org Email: ebcvm_cj@126.com

copyright © 《中国循证心血管医学杂志》编辑部
当您在使用本网站投稿遇到困难时,
请直接将稿件投送到编辑部邮箱ebcvm_cj@126.com